Ablation of CXCR4 expression in cardiomyocytes exacerbates isoproterenol‑induced cell death and heart failure

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Cell Signaling

Background:

• CXCR4 (C-X-C chemokine receptor type 4) is a Gi-coupled receptor vital for cardiovascular development and repair.
• Its precise function within cardiomyocytes, particularly concerning beta-adrenergic signaling, remains unclear.

Purpose of the Study:

• To investigate the role of CXCR4 in cardiomyocytes during beta-adrenergic stress.
• To determine if CXCR4 activation antagonizes beta-adrenoceptor/Gs signaling-induced cardiac dysfunction.

Main Methods:

• Generation of cardiomyocyte-specific CXCR4 knockout (CXCR4-CMKO) mice.
• Assessment of cardiac structure and function under basal and isoproterenol-induced stress conditions.
• In vitro studies using cultured H9C2 cardiomyocytes treated with SDF-1 and isoproterenol.

Main Results:

• CXCR4-CMKO mice exhibited exacerbated cardiac dysfunction, apoptosis, and fibrosis following isoproterenol administration compared to controls.
• SDF-1 treatment protected cultured cardiomyocytes against isoproterenol-induced apoptosis and reduced phospho-Akt levels.
• The protective effects of SDF-1 were abolished by CXCR4 knockdown or Gi inhibitor co-treatment.

Conclusions:

• CXCR4 signaling in cardiomyocytes is crucial for maintaining heart function during beta-adrenergic stress.
• CXCR4 activation confers cardioprotection by antagonizing detrimental beta-adrenoceptor/Gs signaling pathways.